Retro Biosciences, the Sam Altman-backed startup that wants to use AI to develop therapies for extending human lifespan by a decade, is raising a $1B Series A — The San Francisco-based start-up plans to get its first drug into trials this year — Retro Biosciences is raising a $1bn round …
Posted from: this blog via Microsoft Power Automate.